Search results for: methotrexate

Patient’s Journey with Rheumatoid Arthritis Redefines ‘Treat to Target’

Gretchen Henkel | March 1, 2015

Rheumatologist Richard Brasington, MD, says patient John Reigstad’s active participation in treatment decisions shows how much improving quality of life matters

NIAMS’ Intramural Research Programs Foster Spirit of Discovery

Gretchen Henkel | March 1, 2015

National Institute of Arthritis and Musculoskeletal and Skin Diseases program recognized for excellence in training, innovation

2014 ACR/ARHP Annual Meeting: Microbiota Power

Susan Bernstein | March 1, 2015

Gut bacteria may hold clues to breakthrough rheumatic disease treatments

2014 ACR/ARHP Annual Meeting: Innate Immunity at the Core of Rheumatic Disease

Kathy Holliman | March 1, 2015

Rheumatology Research Foundation Memorial Lectureship honors work of renowned rheumatologist Stephen Malawista, MD

2014 ACR/ARHP Annual Meeting: Diagnosis, Management of Sarcoidosis in the Heart, Central Nervous System

Kathy Holliman | March 1, 2015

Without reliable diagnostic tests or evidence-based treatment guidelines, patient symptoms critical to diagnosing disease

2014 ACR/ARHP Annual Meeting: Rheumatoid Arthritis Management Treatment Recommendations

Susan Bernstein | March 1, 2015

The ACR shares highlights of in-development guidelines for RA combination strategies, live vaccines and biologics

Case Report: Rheumatoid Arthritis and Degenerative Disk Disease

Patricia Frisch, PhD; Ronald R. Butendieck, MD; Andy Abril, MD; Peter M. McIntosh, MD; Salim M. Ghazi, MD; Elliot L. Dimberg, MD; Lynn F. Feldman, DO; David G. Lucas, MD; and Andrea Styron, MSR-PT | March 1, 2015

Combination therapy includes abatacept for patient with erosive, chronic RA, underlying osteoarthritis and degenerative disk disease

Seizures in Lupus

Anna Helena Jonsson, MD, PhD, and Shamik Bhattacharyya, MD | March 1, 2015

Case report highlights important twist to differential diagnosis of neuropsychiatric lupus

Glucocorticoid Use in Rheumatoid Arthritis Management Focus of Ongoing Debate

Gretchen Henkel | March 1, 2015

Questions around prescribing steroids as bridge therapy, in long-term low dosages, or low-dose timed-release formulas, or not at all evoke controversy among rheumatologists

Giant Cell Arteritis Challenging to Diagnose, Manage

Sebastian Unizony, MD, and John H. Stone, MD, MPH | March 1, 2015

Common form of primary vasculitis difficult to identify, treat, but latest research suggests potential new therapeutic targets